X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3644) 3644
Publication (151) 151
Newsletter (106) 106
Book Review (35) 35
Book Chapter (18) 18
Magazine Article (11) 11
Newspaper Article (10) 10
Dissertation (9) 9
Book / eBook (2) 2
Conference Proceeding (2) 2
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
buspirone (2261) 2261
male (1647) 1647
humans (1387) 1387
animals (1348) 1348
pharmacology & pharmacy (1234) 1234
rats (1017) 1017
buspirone - pharmacology (864) 864
psychiatry (839) 839
female (796) 796
neurosciences (790) 790
adult (613) 613
buspirone - therapeutic use (609) 609
anxiety (570) 570
serotonin (542) 542
buspirone hydrochloride (490) 490
anti-anxiety agents - pharmacology (486) 486
index medicus (466) 466
dose-response relationship, drug (450) 450
serotonin receptor agonists - pharmacology (402) 402
middle aged (360) 360
diazepam (351) 351
rat (317) 317
mice (313) 313
receptors, serotonin - drug effects (308) 308
clinical neurology (307) 307
5-ht (302) 302
anti-anxiety agents - therapeutic use (297) 297
pyrimidines - pharmacology (291) 291
anxiety disorders - drug therapy (282) 282
buspirone - administration & dosage (266) 266
double-blind method (264) 264
8-oh-dpat (262) 262
benzodiazepines (247) 247
rats, sprague-dawley (246) 246
rats, wistar (243) 243
behavior, animal - drug effects (234) 234
double-blind (222) 222
piperazines - pharmacology (221) 221
receptors (208) 208
treatment outcome (207) 207
depression (201) 201
rats, inbred strains (199) 199
drugs (195) 195
ipsapirone (195) 195
behavior (193) 193
behavioral sciences (193) 193
buspirone - adverse effects (186) 186
serotonin antagonists - pharmacology (185) 185
brain (181) 181
8-hydroxy-2-tetralin - pharmacology (180) 180
anxiolytics (179) 179
aged (173) 173
fluoxetine (168) 168
drug therapy, combination (166) 166
motor activity - drug effects (165) 165
5-ht1a receptor (164) 164
diazepam - pharmacology (161) 161
efficacy (158) 158
receptor (155) 155
time factors (154) 154
antidepressants (152) 152
drug interactions (152) 152
dopamine (150) 150
anxiety - drug therapy (147) 147
serotonin receptor agonists - therapeutic use (145) 145
receptors, serotonin - physiology (144) 144
adolescent (142) 142
8-hydroxy-2-tetralin (141) 141
serotonin uptake inhibitors - therapeutic use (139) 139
agonists (137) 137
research (134) 134
antidepressive agents - therapeutic use (133) 133
5-ht1a receptors (131) 131
gepirone (128) 128
panic disorder (128) 128
receptors, serotonin, 5-ht1 (128) 128
elevated plus-maze (125) 125
rat-brain (125) 125
analysis (124) 124
psychiatric status rating scales (124) 124
animal-models (122) 122
pharmacology (122) 122
serotonin - physiology (122) 122
drug therapy (121) 121
anti-anxiety agents - administration & dosage (120) 120
anxiety disorders - psychology (120) 120
drug administration schedule (120) 120
depressive disorder - drug therapy (118) 118
j ve psychiatry (118) 118
anti-anxiety agents - adverse effects (113) 113
disease models, animal (113) 113
brain - drug effects (109) 109
serotonin - metabolism (109) 109
generalized anxiety disorder (108) 108
psychology, clinical (108) 108
clinical trials as topic (107) 107
major depression (106) 106
neurons (105) 105
placebo (102) 102
stress (102) 102
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3648) 3648
Russian (44) 44
Japanese (34) 34
French (22) 22
German (17) 17
Spanish (17) 17
Portuguese (11) 11
Chinese (9) 9
Hungarian (5) 5
Polish (5) 5
Italian (4) 4
Swedish (2) 2
Czech (1) 1
Dutch (1) 1
Hebrew (1) 1
Korean (1) 1
Persian (1) 1
Serbian (1) 1
Slovak (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European Journal of Clinical Pharmacology, ISSN 0031-6970, 11/2012, Volume 68, Issue 11, pp. 1465 - 1472
Buspirone, a partial 5HT1A agonist and D2 and D3 antagonist, has shown promising antiemetic efficacy when given parenterally in animal models, but its efficacy... 
Biomedicine | Buspirone | Pharmacology/Toxicology | Randomised clinical trial | Antiemetic | Postoperative nausea and vomiting | CATS | MANAGEMENT | 5-HT1A RECEPTORS | ONDANSETRON | AGONISTS | FLESINOXAN | PROPHYLAXIS | ANXIOLYTICS | PHARMACOLOGY & PHARMACY | 5-HT(1A) RECEPTOR | CISPLATIN-INDUCED EMESIS | Anti-Anxiety Agents - administration & dosage | Injections, Intravenous | Buspirone - blood | Dopamine Antagonists - pharmacokinetics | Humans | Middle Aged | Receptors, Dopamine D3 - metabolism | Antiemetics - administration & dosage | Male | Buspirone - pharmacokinetics | Receptors, Dopamine D2 - metabolism | Dopamine Antagonists - administration & dosage | Incidence | Dose-Response Relationship, Drug | Young Adult | Anti-Anxiety Agents - pharmacokinetics | Buspirone - administration & dosage | Antiemetics - pharmacokinetics | Antiemetics - therapeutic use | Aged, 80 and over | Adult | Anti-Anxiety Agents - adverse effects | Antiemetics - adverse effects | Female | Anti-Anxiety Agents - therapeutic use | Buspirone - adverse effects | Receptors, Dopamine D3 - antagonists & inhibitors | Buspirone - therapeutic use | Receptor, Serotonin, 5-HT1A - metabolism | Postoperative Nausea and Vomiting - epidemiology | Double-Blind Method | Dopamine Antagonists - therapeutic use | Serotonin 5-HT1 Receptor Agonists - therapeutic use | Serotonin 5-HT1 Receptor Agonists - adverse effects | Postoperative Nausea and Vomiting - prevention & control | Receptor, Serotonin, 5-HT1A - chemistry | Buspirone - analogs & derivatives | Dopamine Antagonists - adverse effects | Serotonin 5-HT1 Receptor Agonists - administration & dosage | Aged | Dopamine D2 Receptor Antagonists | Postoperative Nausea and Vomiting - blood | Prevention | Complications and side effects | Buspirone hydrochloride | Adults | Nausea | Analysis | Postoperative period | Vomiting | Clinical trials | Pharmacology | Drug therapy | Clinical outcomes
Journal Article
Journal Article
Journal Article
Drug and Alcohol Dependence, ISSN 0376-8716, 2015, Volume 156, pp. 29 - 37
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 03/2014, Volume 124, Issue 3, pp. 1340 - 1349
Journal Article
Neuropharmacology, ISSN 0028-3908, 08/2013, Volume 71, pp. 83 - 97
Serotonin (5-HT) is a neurotransmitter that is involved in many behavioral functions, including the organization of defense, and its putative pathological... 
Fear | Zebrafish | Anxiety | Serotonin | Scototaxis | Geotaxis | 5-HYDROXYTRYPTAMINE RELEASE | RAT | 5-HT1A RECEPTOR ANTAGONISTS | REUPTAKE INHIBITORS | DORSAL RAPHE | ADULT ZEBRAFISH | ELEVATED PLUS-MAZE | T-MAZE | NEUROSCIENCES | IN-VIVO | PHARMACOLOGY & PHARMACY | BRAIN | Anti-Anxiety Agents - administration & dosage | Fenclonine - administration & dosage | Spiro Compounds - therapeutic use | Anxiety - drug therapy | Piperidones - therapeutic use | Serotonin - chemistry | Brain - metabolism | Pyridines - adverse effects | Fenclonine - adverse effects | Behavior, Animal - drug effects | Hyperkinesis - chemically induced | Neurons - metabolism | Serotonin 5-HT1 Receptor Antagonists - administration & dosage | Anti-Anxiety Agents - therapeutic use | Buspirone - therapeutic use | Fluoxetine - adverse effects | Disease Models, Animal | Pyridines - administration & dosage | Nerve Tissue Proteins - agonists | Piperazines - therapeutic use | Piperazines - adverse effects | Extracellular Fluid - drug effects | Brain - drug effects | Serotonin Uptake Inhibitors - administration & dosage | Fluoxetine - administration & dosage | Piperazines - administration & dosage | Fenclonine - therapeutic use | Spiro Compounds - administration & dosage | Piperidones - adverse effects | Hyperkinesis - metabolism | Spiro Compounds - adverse effects | Dose-Response Relationship, Drug | Buspirone - administration & dosage | Protein Isoforms - metabolism | Protein Isoforms - agonists | Anti-Anxiety Agents - adverse effects | Buspirone - adverse effects | Fluoxetine - therapeutic use | Neurons - drug effects | Anxiety - metabolism | Pyridines - therapeutic use | Nerve Tissue Proteins - antagonists & inhibitors | Serotonin Uptake Inhibitors - therapeutic use | Serotonin Uptake Inhibitors - adverse effects | Serotonin 5-HT1 Receptor Agonists - therapeutic use | Serotonin 5-HT1 Receptor Agonists - adverse effects | Serotonin 5-HT1 Receptor Antagonists - adverse effects | Nerve Tissue Proteins - metabolism | Piperidones - administration & dosage | Extracellular Fluid - metabolism | Serotonin 5-HT1 Receptor Antagonists - therapeutic use | Animals | Serotonin - metabolism | Serotonin 5-HT1 Receptor Agonists - administration & dosage | Anxiety - chemically induced | Protein Isoforms - antagonists & inhibitors | Phenols | Buspirone hydrochloride | Fluoxetine
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2006, Volume 354, Issue 12, pp. 1243 - 1252
Journal Article
Journal Article
Drug and Alcohol Dependence, ISSN 0376-8716, 2015, Volume 156, pp. e23 - e23
Journal Article